{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:38:18Z","timestamp":1772051898370,"version":"3.50.1"},"reference-count":271,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T00:00:00Z","timestamp":1353628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutr. Res. Rev."],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:p>HIV-associated lipodystrophy syndrome (HALS), comprising metabolic and morphological alterations, is a known side effect of highly active antiretroviral therapy (HAART). Evidence for the role of nutrition in the management of the systemic parameters of HALS is currently limited. In the present paper we review the current knowledge base surrounding HALS, focusing particularly on the role of nutrition in mitigating the systemic parameters of the syndrome. Reported prevalence of HALS was found to vary from 9 to 83\u00a0% due to lack of a standardised definition, as well as variations in assessment methods and in the study population used. HALS is associated with both morphological (lipoatrophy, lipohypertrophy) and metabolic (dyslipidaemia, glucose intolerance, diabetes, hypertension, endothelial dysfunction and atherosclerosis) alterations, which may occur singly or in combination, and are associated with an increased risk of CVD. HAART-induced adipocyte inflammation, oxidative stress and macrophage infiltration, as well as altered adipocyte function and mitochondrial toxicity, have been shown to be central to the development of HALS. The adipocyte, therefore, represents a plausible target for treatment. Pharmacological and surgical treatment interventions have shown effect. However, their use is associated with numerous adverse effects and complications. Targeted lifestyle interventions may provide a useful alternative for managing HALS owing to their safety and tolerability. A Mediterranean-style diet has been found to be effective in improving the systemic parameters of HALS. Furthermore, the effects of<jats:italic>n<\/jats:italic>-3 PUFA supplementation are encouraging and future randomised controlled trials investigating the beneficial effects of<jats:italic>n<\/jats:italic>-3 PUFA in HALS are justified.<\/jats:p>","DOI":"10.1017\/s0954422411000138","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T12:11:29Z","timestamp":1353672689000},"page":"267-287","source":"Crossref","is-referenced-by-count":25,"title":["Nutrition and the HIV-associated lipodystrophy syndrome"],"prefix":"10.1017","volume":"25","author":[{"given":"Cathr\u00edona Rosemary","family":"Loonam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2012,11,23]]},"reference":[{"key":"S0954422411000138_ref149","doi-asserted-by":"publisher","DOI":"10.1016\/S1413-8670(10)70057-X"},{"key":"S0954422411000138_ref203","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/135965350701200704","article-title":"Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors","volume":"12","author":"Venhoff","year":"2007","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref172","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32833f147f"},{"key":"S0954422411000138_ref150","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200110190-00013"},{"key":"S0954422411000138_ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-4-16"},{"key":"S0954422411000138_ref33","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200304001-00010"},{"key":"S0954422411000138_ref181","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/135965350701200407","article-title":"Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages","volume":"12","author":"Lagathu","year":"2007","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref220","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.10.019"},{"key":"S0954422411000138_ref93","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-407"},{"key":"S0954422411000138_ref94","doi-asserted-by":"publisher","DOI":"10.1089\/10872910260196404"},{"key":"S0954422411000138_ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh330"},{"key":"S0954422411000138_ref77","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200101260-00024"},{"key":"S0954422411000138_ref204","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.716-723.2002"},{"key":"S0954422411000138_ref218","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.216192"},{"key":"S0954422411000138_ref54","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.22.2621"},{"key":"S0954422411000138_ref48","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200312150-00003"},{"key":"S0954422411000138_ref83","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/135965350300800412","article-title":"Correlates of risk of adipose tissue alterations and their modifications over time in HIV-1-infected women treated with antiretroviral therapy","volume":"8","author":"Galli","year":"2003","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref29","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1491"},{"key":"S0954422411000138_ref84","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06413-3"},{"key":"S0954422411000138_ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.asj.2008.05.002"},{"key":"S0954422411000138_ref74","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31819c16f4"},{"key":"S0954422411000138_ref263","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199603010-00006"},{"key":"S0954422411000138_ref180","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00056.2003"},{"key":"S0954422411000138_ref258","doi-asserted-by":"publisher","DOI":"10.1086\/497273"},{"key":"S0954422411000138_ref255","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/86.4.1009"},{"key":"S0954422411000138_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)63513-1"},{"key":"S0954422411000138_ref252","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-3067"},{"key":"S0954422411000138_ref250","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/135965350701200113","article-title":"Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Sutinen","year":"2007","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref246","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199702000-00008"},{"key":"S0954422411000138_ref243","doi-asserted-by":"publisher","DOI":"10.1071\/SH09065"},{"key":"S0954422411000138_ref159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.04.049"},{"key":"S0954422411000138_ref242","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200210180-00014"},{"key":"S0954422411000138_ref60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00537.x"},{"key":"S0954422411000138_ref234","doi-asserted-by":"publisher","DOI":"10.1310\/hct1105-270"},{"key":"S0954422411000138_ref233","doi-asserted-by":"publisher","DOI":"10.1097\/00003677-200110000-00007"},{"key":"S0954422411000138_ref79","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04056-3"},{"key":"S0954422411000138_ref227","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00682.x"},{"key":"S0954422411000138_ref226","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00761.x"},{"key":"S0954422411000138_ref223","doi-asserted-by":"publisher","DOI":"10.1097\/01.sap.0000248128.33465.83"},{"key":"S0954422411000138_ref222","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe078099"},{"key":"S0954422411000138_ref219","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2011.558839"},{"key":"S0954422411000138_ref217","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.4.472"},{"key":"S0954422411000138_ref148","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00720.x"},{"key":"S0954422411000138_ref216","doi-asserted-by":"publisher","DOI":"10.1310\/hct1101-39"},{"key":"S0954422411000138_ref215","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-006-5022-y"},{"key":"S0954422411000138_ref212","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.72.12.1113"},{"key":"S0954422411000138_ref210","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181a5701c"},{"key":"S0954422411000138_ref188","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn251"},{"key":"S0954422411000138_ref221","doi-asserted-by":"publisher","DOI":"10.1310\/hct1003-168"},{"key":"S0954422411000138_ref205","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/135965350701200610","article-title":"Mitochondrial toxicity of indinavir, stavudine and zidovudine involves multiple cellular targets in white and brown adipocytes","volume":"12","author":"Viengchareun","year":"2007","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref257","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31802c2f3d"},{"key":"S0954422411000138_ref47","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817af461"},{"key":"S0954422411000138_ref213","doi-asserted-by":"publisher","DOI":"10.1086\/378131"},{"key":"S0954422411000138_ref89","unstructured":"International Diabetes Federation (2005) Global guideline for type 2 diabetes. http:\/\/www.idf.org\/Global_guideline."},{"key":"S0954422411000138_ref248","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1602793"},{"key":"S0954422411000138_ref78","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200101260-00013"},{"key":"S0954422411000138_ref56","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2003.00159.x"},{"key":"S0954422411000138_ref207","doi-asserted-by":"publisher","DOI":"10.1310\/hct0906-407"},{"key":"S0954422411000138_ref152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2007.09.002"},{"key":"S0954422411000138_ref186","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2005.01576.x"},{"key":"S0954422411000138_ref75","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/135965350901400307","article-title":"Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin","volume":"14","author":"Zannou","year":"2009","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350501000105","article-title":"Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV Cohort Study","volume":"10","author":"Young","year":"2005","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref62","doi-asserted-by":"publisher","DOI":"10.1177\/1545109711401750"},{"key":"S0954422411000138_ref80","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200209010-00007"},{"key":"S0954422411000138_ref256","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(93)90070-7"},{"key":"S0954422411000138_ref100","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199909100-00009"},{"key":"S0954422411000138_ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2007.02.020"},{"key":"S0954422411000138_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)64011-1"},{"key":"S0954422411000138_ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.02.012"},{"key":"S0954422411000138_ref107","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11518-5"},{"key":"S0954422411000138_ref131","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200110190-00020"},{"key":"S0954422411000138_ref157","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.104.3.257"},{"key":"S0954422411000138_ref121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0010019"},{"key":"S0954422411000138_ref13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.11.4721-4732.2005"},{"key":"S0954422411000138_ref50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2003.00167.x"},{"key":"S0954422411000138_ref86","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"S0954422411000138_ref271","doi-asserted-by":"publisher","DOI":"10.1177\/014860719602000143"},{"key":"S0954422411000138_ref132","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00017"},{"key":"S0954422411000138_ref120","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.100.7.700"},{"key":"S0954422411000138_ref82","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12656-6"},{"key":"S0954422411000138_ref208","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/135965350801300103","article-title":"Contribution of mitochondrial dysfunction and oxidative stress to cellular premature senescence induced by antiretroviral thymidine analogues","volume":"13","author":"Caron","year":"2008","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref229","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-1-200901060-00022"},{"key":"S0954422411000138_ref72","doi-asserted-by":"publisher","DOI":"10.1310\/hct0905-314"},{"key":"S0954422411000138_ref70","first-page":"199","article-title":"Lipodystrophy and dyslipidemia among patients taking first-line, World Health Organization-recommended highly active antiretroviral therapy regimens in Western India","volume":"39","author":"Pujari","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"S0954422411000138_ref262","first-page":"237","article-title":"Effect of omega-3 fatty acids on the lipid structure of HIV-positive patients on antiretroviral therapy: personal observation of 20 subjects (article in Italian)","volume":"15","author":"Ranieri","year":"2007","journal-title":"Infez Med"},{"key":"S0954422411000138_ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199806000-00001"},{"key":"S0954422411000138_ref57","first-page":"605","article-title":"Prevalence of lipodystrophy in Thai-HIV infected patients","volume":"87","author":"Puttawong","year":"2004","journal-title":"J Med Assoc Thai"},{"key":"S0954422411000138_ref65","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200107270-00008"},{"key":"S0954422411000138_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0753-3322(99)80063-8"},{"key":"S0954422411000138_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)90004-3"},{"key":"S0954422411000138_ref3","unstructured":"Health Protection Agency (2010) HIV in the United Kingdom: 2010. http:\/\/www.hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1287145367237."},{"key":"S0954422411000138_ref95","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200308150-00004"},{"key":"S0954422411000138_ref63","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001070-00005"},{"key":"S0954422411000138_ref67","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-2662.2001.00100.x"},{"key":"S0954422411000138_ref105","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041811"},{"key":"S0954422411000138_ref230","doi-asserted-by":"publisher","DOI":"10.1249\/01.mss.0000191347.73848.80"},{"key":"S0954422411000138_ref91","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000111245.75752.C6"},{"key":"S0954422411000138_ref175","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832995fa"},{"key":"S0954422411000138_ref254","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2003.50103"},{"key":"S0954422411000138_ref202","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.09.018"},{"key":"S0954422411000138_ref112","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2010.00845.x"},{"key":"S0954422411000138_ref238","doi-asserted-by":"publisher","DOI":"10.1086\/375887"},{"key":"S0954422411000138_ref109","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11443-X"},{"key":"S0954422411000138_ref165","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)78644-X"},{"key":"S0954422411000138_ref209","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350601100109","article-title":"Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions","volume":"11","author":"Walker","year":"2006","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref123","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/135965350601100202","article-title":"In combination, nucleoside reverse transcriptase inhibitors have significant effects on 3T3-L1 adipocyte lipid accumulation and survival","volume":"11","author":"Kosmiski","year":"2006","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref214","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200203080-00008"},{"key":"S0954422411000138_ref155","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.583856"},{"key":"S0954422411000138_ref130","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200112070-00007"},{"key":"S0954422411000138_ref46","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000243093.34652.41"},{"key":"S0954422411000138_ref68","doi-asserted-by":"publisher","DOI":"10.1086\/344055"},{"key":"S0954422411000138_ref59","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318158c0a6"},{"key":"S0954422411000138_ref2","unstructured":"World Health Organization (2010) Fast facts on HIV. http:\/\/www.who.int\/hiv\/data\/fast_facts\/en\/index.html."},{"key":"S0954422411000138_ref183","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"S0954422411000138_ref49","doi-asserted-by":"publisher","DOI":"10.1177\/1055329004271187"},{"key":"S0954422411000138_ref90","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldm030"},{"key":"S0954422411000138_ref88","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.537212"},{"key":"S0954422411000138_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328334344e"},{"key":"S0954422411000138_ref25","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1075"},{"key":"S0954422411000138_ref151","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/135965350501000706","article-title":"Data collection of adverse events of anti-HIV Drugs Study Group. Predictors of hypertension and changes of blood pressure in HIV-infected patients","volume":"10","author":"Thi\u00e9baut","year":"2005","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(98)00025-4"},{"key":"S0954422411000138_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2010.04.011"},{"key":"S0954422411000138_ref35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/QAI.0b013e31815e7251","article-title":"Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy","volume":"47","author":"Bozzette","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"S0954422411000138_ref211","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2010.00906.x"},{"key":"S0954422411000138_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2010.05.020"},{"key":"S0954422411000138_ref28","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.10.1179"},{"key":"S0954422411000138_ref4","unstructured":"Food and Drug Administration (2011) Antiretroviral drugs used in the treatment of HIV infection. http:\/\/www.fda.gov\/ForConsumers\/ByAudience\/ForPatientAdvocates\/HIVandAIDSActivities\/ucm118915.htm."},{"key":"S0954422411000138_ref26","unstructured":"Lumpkin MM (1997) Reports of diabetes and hyperglycemia in patients receiving protease inhibitors for the treatment of human immunodeficiency virus (HIV). http:\/\/www.fda.gov\/ForConsumers\/ByAudience\/ForPatientAdvocates\/HIVandAIDSActivities\/ucm151115.htm."},{"key":"S0954422411000138_ref261","doi-asserted-by":"publisher","DOI":"10.1310\/hct0806-400"},{"key":"S0954422411000138_ref170","doi-asserted-by":"publisher","DOI":"10.1016\/S1413-8670(10)70053-2"},{"key":"S0954422411000138_ref103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00305.x"},{"key":"S0954422411000138_ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540260059037"},{"key":"S0954422411000138_ref32","doi-asserted-by":"publisher","DOI":"10.1086\/511679"},{"key":"S0954422411000138_ref232","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200110190-00021"},{"key":"S0954422411000138_ref110","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.7.766"},{"key":"S0954422411000138_ref76","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199903110-00004"},{"key":"S0954422411000138_ref10","unstructured":"Gilead Sciences Inc. (2001) VIREAD (tenofovir): highlights of prescribing information. http:\/\/www.gilead.com\/pdf\/viread_pi.pdf."},{"key":"S0954422411000138_ref162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2008.02.006"},{"key":"S0954422411000138_ref267","doi-asserted-by":"publisher","DOI":"10.1079\/PNS2002166"},{"key":"S0954422411000138_ref64","doi-asserted-by":"publisher","DOI":"10.1086\/317477"},{"key":"S0954422411000138_ref38","doi-asserted-by":"publisher","DOI":"10.1086\/648080"},{"key":"S0954422411000138_ref37","doi-asserted-by":"publisher","DOI":"10.1097\/HJR.0b013e328336a150"},{"key":"S0954422411000138_ref228","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2009.0029"},{"key":"S0954422411000138_ref114","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90536-7"},{"key":"S0954422411000138_ref236","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2001.90.1.133"},{"key":"S0954422411000138_ref178","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dym135"},{"key":"S0954422411000138_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jana.2006.03.001"},{"key":"S0954422411000138_ref244","doi-asserted-by":"publisher","DOI":"10.1086\/338402"},{"key":"S0954422411000138_ref200","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-870526"},{"key":"S0954422411000138_ref199","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200411050-00004"},{"key":"S0954422411000138_ref126","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200104130-00008"},{"key":"S0954422411000138_ref190","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.10.2929"},{"key":"S0954422411000138_ref115","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.22.2978"},{"key":"S0954422411000138_ref161","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2006.03.013"},{"key":"S0954422411000138_ref97","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp240"},{"key":"S0954422411000138_ref241","doi-asserted-by":"publisher","DOI":"10.2174\/157016209788680589"},{"key":"S0954422411000138_ref98","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)08468-2"},{"key":"S0954422411000138_ref140","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200109280-00010"},{"key":"S0954422411000138_ref27","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907090-00001"},{"key":"S0954422411000138_ref113","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90225-8"},{"key":"S0954422411000138_ref99","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199912240-00002"},{"key":"S0954422411000138_ref240","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200008180-00020"},{"key":"S0954422411000138_ref102","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/69.6.1162"},{"key":"S0954422411000138_ref6","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.1992.11705596"},{"key":"S0954422411000138_ref11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.45.3.262"},{"key":"S0954422411000138_ref191","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.04.010"},{"key":"S0954422411000138_ref117","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-9684(15)30828-2"},{"key":"S0954422411000138_ref106","doi-asserted-by":"publisher","DOI":"10.1086\/430379"},{"key":"S0954422411000138_ref260","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200407010-00017"},{"key":"S0954422411000138_ref143","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200403050-00008"},{"key":"S0954422411000138_ref265","doi-asserted-by":"publisher","DOI":"10.1016\/S0261-5614(97)80038-6"},{"key":"S0954422411000138_ref251","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.02.029"},{"key":"S0954422411000138_ref164","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79053-X"},{"key":"S0954422411000138_ref266","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00449.x"},{"key":"S0954422411000138_ref87","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.1.132"},{"key":"S0954422411000138_ref116","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-004-0268-9"},{"key":"S0954422411000138_ref69","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200301010-00007"},{"key":"S0954422411000138_ref119","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03391-1"},{"key":"S0954422411000138_ref187","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702223200"},{"key":"S0954422411000138_ref141","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183629.20041.bb"},{"key":"S0954422411000138_ref53","doi-asserted-by":"publisher","DOI":"10.1086\/338811"},{"key":"S0954422411000138_ref122","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00325.x"},{"key":"S0954422411000138_ref51","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2001.00073.x"},{"key":"S0954422411000138_ref124","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114509338817"},{"key":"S0954422411000138_ref268","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2006.04.003"},{"key":"S0954422411000138_ref194","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2008.07.009"},{"key":"S0954422411000138_ref264","doi-asserted-by":"publisher","DOI":"10.1071\/SH06001"},{"key":"S0954422411000138_ref225","first-page":"126","article-title":"Disorders of body fat distribution in HIV-1-infected patients","volume":"11","author":"Moreno","year":"2009","journal-title":"AIDS Rev"},{"key":"S0954422411000138_ref128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030052"},{"key":"S0954422411000138_ref129","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.069583"},{"key":"S0954422411000138_ref249","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-1293.2009.00817.x","article-title":"No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial","volume":"11","author":"Calmy","year":"2010","journal-title":"HIV Med"},{"key":"S0954422411000138_ref247","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1225625"},{"key":"S0954422411000138_ref22","first-page":"7","article-title":"HIV lipodystrophy syndrome","volume":"44","author":"Omolayo","year":"2008","journal-title":"Hosp Physician"},{"key":"S0954422411000138_ref134","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.6.931"},{"key":"S0954422411000138_ref136","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00017"},{"key":"S0954422411000138_ref66","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200210010-00012"},{"key":"S0954422411000138_ref167","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(08)60423-7","article-title":"Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration","volume":"371","author":"Sabin","year":"2008","journal-title":"Lancet"},{"key":"S0954422411000138_ref34","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.4.457"},{"key":"S0954422411000138_ref138","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1097\/01.hjr.0000368191.86614.5a","article-title":"The global burden of diabetes and its complications: an emerging pandemic","volume":"17","author":"van Dieren","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"S0954422411000138_ref142","doi-asserted-by":"publisher","DOI":"10.1177\/1545109710373832"},{"key":"S0954422411000138_ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2008.09.011"},{"key":"S0954422411000138_ref55","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200309010-00008"},{"key":"S0954422411000138_ref144","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.4.918"},{"key":"S0954422411000138_ref145","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32827038d0"},{"key":"S0954422411000138_ref108","doi-asserted-by":"publisher","DOI":"10.2310\/6650.2005.00001"},{"key":"S0954422411000138_ref146","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.2007.S5"},{"key":"S0954422411000138_ref154","doi-asserted-by":"publisher","DOI":"10.2174\/157016210791330419"},{"key":"S0954422411000138_ref173","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2009.113"},{"key":"S0954422411000138_ref147","doi-asserted-by":"publisher","DOI":"10.1086\/507333"},{"key":"S0954422411000138_ref158","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2010.0007"},{"key":"S0954422411000138_ref163","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328300581d"},{"key":"S0954422411000138_ref224","doi-asserted-by":"publisher","DOI":"10.1016\/j.asj.2007.12.003"},{"key":"S0954422411000138_ref160","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.213603"},{"key":"S0954422411000138_ref61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/135965350200700306","article-title":"Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV-positive patients","volume":"7","author":"Seminari","year":"2002","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref235","doi-asserted-by":"publisher","DOI":"10.1258\/095646207782193795"},{"key":"S0954422411000138_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.04.035"},{"key":"S0954422411000138_ref182","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2006.114"},{"key":"S0954422411000138_ref171","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.10.1072"},{"key":"S0954422411000138_ref201","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1177\/135965350701200809","article-title":"A 6-month interruption of antiretroviral therapy improves adipose tissue function in HIV-infected patients: the ANRS EP29 Lipostop Study","volume":"12","author":"Kim","year":"2007","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref176","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(91)90861-B"},{"key":"S0954422411000138_ref40","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/78.4.790"},{"key":"S0954422411000138_ref177","doi-asserted-by":"publisher","DOI":"10.1086\/521936"},{"key":"S0954422411000138_ref139","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60679-X"},{"key":"S0954422411000138_ref179","doi-asserted-by":"publisher","DOI":"10.1086\/655765"},{"key":"S0954422411000138_ref184","doi-asserted-by":"publisher","DOI":"10.1086\/599986"},{"key":"S0954422411000138_ref127","article-title":"Metabolic syndrome in black people of the African diaspora: the paradox of current classification, definition and criteria","volume":"19","author":"Gaillard","year":"2009","journal-title":"Ethn Dis"},{"key":"S0954422411000138_ref189","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-201X.2004.01383.x"},{"key":"S0954422411000138_ref169","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2008.008295"},{"key":"S0954422411000138_ref52","doi-asserted-by":"publisher","DOI":"10.1310\/BRE5-448N-WUPU-JWVL"},{"key":"S0954422411000138_ref135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00760.x"},{"key":"S0954422411000138_ref192","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.350"},{"key":"S0954422411000138_ref193","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/135965350601100610","article-title":"HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV-1\/HAART-associated lipodystrophy","volume":"11","author":"Giralt","year":"2006","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref156","doi-asserted-by":"publisher","DOI":"10.1385\/CT:4:3:261"},{"key":"S0954422411000138_ref196","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000242815.80462.5a"},{"key":"S0954422411000138_ref195","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.09.064"},{"key":"S0954422411000138_ref197","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02367.x"},{"key":"S0954422411000138_ref125","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702008000400002"},{"key":"S0954422411000138_ref239","doi-asserted-by":"publisher","DOI":"10.1086\/375225"},{"key":"S0954422411000138_ref118","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305230-00010"},{"key":"S0954422411000138_ref1","doi-asserted-by":"publisher","DOI":"10.1086\/651476"},{"key":"S0954422411000138_ref237","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2733"},{"key":"S0954422411000138_ref81","doi-asserted-by":"publisher","DOI":"10.1086\/339866"},{"key":"S0954422411000138_ref92","unstructured":"US National Institutes of Health (2004) DAIDS HIV Vaccines and Research Program NIoH. Division of AIDS (DAIDS) revised toxicity tables for grading the severity of adult and pediatric adverse events experiences, version 1.0. Washington, DC. http:\/\/www.ucdmc.ucdavis.edu\/clinicaltrials\/documents\/DAIDS_AE_GradingTable_FinalDec2004.pdf."},{"key":"S0954422411000138_ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-009-9330-2"},{"key":"S0954422411000138_ref259","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31815bace2"},{"key":"S0954422411000138_ref245","first-page":"552","article-title":"Eucaloric substitution of medium chain triglycerides for dietary long chain fatty acids improves body composition and lipid profile in a patient with human immunodeficiency virus lipodystrophy","volume":"21","author":"V\u00e1zquez","year":"2006","journal-title":"Nutr Hosp"},{"key":"S0954422411000138_ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-277X.2010.01068.x"},{"key":"S0954422411000138_ref111","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31804a85b0"},{"key":"S0954422411000138_ref43","doi-asserted-by":"publisher","DOI":"10.1086\/322680"},{"key":"S0954422411000138_ref101","first-page":"1332","article-title":"Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting","volume":"82","author":"Grinspoon","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"S0954422411000138_ref270","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199801000-00007"},{"key":"S0954422411000138_ref21","first-page":"3","article-title":"Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy","volume":"9","author":"Mallon","year":"2007","journal-title":"AIDS Rev"},{"key":"S0954422411000138_ref174","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/135965350801300215","article-title":"Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial","volume":"13","author":"Phillips","year":"2008","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref231","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199907300-00015"},{"key":"S0954422411000138_ref168","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80283-7"},{"key":"S0954422411000138_ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2005.00309.x"},{"key":"S0954422411000138_ref198","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90224.2008"},{"key":"S0954422411000138_ref253","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.10.012"},{"key":"S0954422411000138_ref18","doi-asserted-by":"publisher","DOI":"10.1086\/514639"},{"key":"S0954422411000138_ref166","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022048"},{"key":"S0954422411000138_ref185","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8450"},{"key":"S0954422411000138_ref137","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-10-199711150-00016"},{"key":"S0954422411000138_ref133","doi-asserted-by":"publisher","DOI":"10.1086\/429295"},{"key":"S0954422411000138_ref104","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/135965350300800614","article-title":"Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level","volume":"8","author":"Nolan","year":"2003","journal-title":"Antivir Ther"},{"key":"S0954422411000138_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.09.008"},{"key":"S0954422411000138_ref269","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2009.02.008"},{"key":"S0954422411000138_ref153","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31819367cd"},{"key":"S0954422411000138_ref30","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"S0954422411000138_ref206","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200211080-00009"},{"key":"S0954422411000138_ref85","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200105040-00005"}],"container-title":["Nutrition Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0954422411000138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T21:27:31Z","timestamp":1714598851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0954422411000138\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,23]]},"references-count":271,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0954422411000138"],"URL":"https:\/\/doi.org\/10.1017\/s0954422411000138","relation":{},"ISSN":["0954-4224","1475-2700"],"issn-type":[{"value":"0954-4224","type":"print"},{"value":"1475-2700","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,23]]}}}